Contact: Errol Zhou (Mr.) Tel: +86-551-65523315 Mobile/WhatsApp: +86 17705606359 QQ: 196299583 Skype: [email protected] Email: [email protected] Add: 1002, Huanmao Building, No.105, Mengcheng Road, Hefei City, 230061, China A few days ago, Novo Nordisk announced that the US FDA has approved the new indication of 0.5 mg or 1 mg of Ozempic (semaglutide, Somalutide) injection for reducing the main symptoms of adult patients with type 2 diabetes and known heart disease
This results in lower blood sugar levels and ultimately leads to weight loss as confirmed by one of the clinical trials where subjects reported a 15% loss in body weight
FIPCareGroup .com B12 vitamins, liver and anemia
No, the needle size remains the same regardless of your dosage
For now, subcutaneous injection remains the standard delivery method
You are required to follow your healthcare providers recommendations and adhere to prescribed regimens.